Manufacturing companies should actively prepare for heightened antitrust scrutiny of their business practices in 2023, including practices that have not traditionally garnered the focus.
On February 3, 2023, the Antitrust Division of the US Department of Justice (DOJ) withdrew its support for three long-standing policy statements relating to enforcement
On February 3, 2023, the Justice Department's Antitrust Division withdrew three "overly permissive" guidance documents related to competition enforcement in the health care sector:.
On February 3, 2023, the Antitrust Division of the Department of Justice (DOJ) withdrew its nearly 30-year-old guidance on information exchanges in the healthcare industry, including.
With little warning the Antitrust Division of the U.S. Department of Justice announced on February 3 the withdrawal of three critical pieces of guidance for the health care industry.